The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
travoprost ophthalmic solution usp, 0.004% · Solution/ Drops
2 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Prostaglandin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- tafluprost opthalmic· 1 maker
- travoprost (isomer free)· 1 maker
- travoprost ophthalmic solution, 0.004%· 1 maker
- travoprost intracameral· 2 makers
- travoprost ophthalmic· 2 makers
- travoprost ophthalmic solution· 4 makers
- dinoprostone· 7 makers
- tafluprost· 12 makers
- travoprost· 16 makers
- alprostadil· 18 makers
- carboprost tromethamine· 26 makers
- bimatoprost· 38 makers
Common questions
- Is Travoprost ophthalmic solution usp, 0.004% in shortage right now?
- No. FDA does not currently list Travoprost ophthalmic solution usp, 0.004% in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Travoprost ophthalmic solution usp, 0.004%?
- 1 company has marketed Travoprost ophthalmic solution usp, 0.004% in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.